Scandinavian Candesartan Acute Stroke Trial.

Trial Profile

Scandinavian Candesartan Acute Stroke Trial.

Completed
Phase of Trial: Phase III

Latest Information Update: 25 Sep 2014

At a glance

  • Drugs Candesartan cilexetil (Primary)
  • Indications Cardiovascular disorders; Hypertension; Stroke
  • Focus Therapeutic Use
  • Acronyms SCAST
  • Most Recent Events

    • 04 Oct 2012 Quality-of-life outcomes presented at the 24th Scientific Meeting of the International Society of Hypertension.
    • 04 Oct 2012 Results assessing the long-term effect of treatment on cognitive function presented at the 24th Scientific Meeting of the International Society of Hypertension.
    • 20 Jun 2011 Results presented at the 21st European Meeting on Hypertension.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top